A link between unconscious conflicts and conscious anxiety disorder symptoms shown in new study, which lends empirical support to Freud’s key theories as well as to psychoanalysis.
Research into alcohol’s effect on juvenile rats shows they have an ability to build up a physical, but not cognitive, tolerance over the short term.
Patients seen at the Cleveland Clinic Sleep Disorders Center who used positive airway pressure (PAP) to treat their obstructive sleep apnea (OSA) had improvements in their depressive symptoms, even if they followed the prescribed PAP regimen only partly, a new study reports.
Getting a good night’s rest continues to be of utmost importance to your health. New data from researchers at the University of Alabama at Birmingham shows not getting enough sleep can increase the risk for stroke symptoms in people with a healthy body mass index who are at low risk for obstructive sleep apnea and have no […]
A study of 91 patients at a university medical center suggests that a troubled early parent-child relationship in combination with a severe life event in the past year may be associated with immune responses to a basal cell carcinoma tumor, the most common skin cancer, according to a report in the June issue of Archives […]
Sound, restful sleep may be just a dream for millions of Americans with strained family relationships. That is the finding of a new study published in the Journal of Health and Social Behavior.
Chronic exposure to cocaine reduces the expression of a protein known to regulate brain plasticity, according to new, in vivo research on the molecular basis of cocaine addiction. That reduction drives structural changes in the brain, which produce greater sensitivity to the rewarding effects of cocaine. The finding suggests a potential new target for development […]
In the current issue of Psychotherapy and Psychosomatics, researchers failed to find evidence for the use of aripiprazole (Abilify®) in depression. In this study the investigators assessed the efficacy of low-dose aripiprazole added to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) with inadequate response to prior ADT.